Century Therapeutics Inc.

IPSC | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.89

+$0.04 (+2.16%)

Sep 22, 2026, 1:24 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $160.15M

Enterprise Value $75.07M

Beta 1.60

Average Volume 1.02M

Shares Outstanding (Diluted) 205.78M

Shares Change YoY 138.62%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US15673T1007

Price Performance

Price Change 1M -10.6%

Price Change 3M -23.2%

Price Change 6M -10.6%

Price Change YTD 86.0%

Price Change 1Y 285.4%

Price Change 3Y -14.8%

Price Change 5Y -92.0%

1M CAGR (ann.) -7.5%

1Y CAGR (ann.) 264.9%

5Y CAGR (ann.) -41.8%

All-Time CAGR -38.0%

Valuation

PE Ratio -1.78

Forward PE N/A

PEG Ratio 0.00

Forward PEG 0.12

PS Ratio N/A

Forward PS 42.90

PB Ratio 0.69

P/FCF Ratio -1.81

P/Adj. FCF Ratio -1.70

P/OCF Ratio -4.40

EV/Sales N/A

EV/EBIT -0.72

EV/EBITDA -0.79

EV/FCF -0.85

Earnings Yield -56.2%

FCF Yield -55.3%

Adj. FCF Yield -58.8%

Financial Health

Net Cash $119.71M

Total Debt $34.63M

Cash & Short-Term Investments $119.71M

Total Assets $287.01M

Current Ratio 8.28

Quick Ratio 8.28

Debt / Equity Ratio 0.15

Debt / EBITDA -0.36

Debt / FCF -0.39

OCF / Debt -2.51

Interest Coverage 0.00

Altman Z-Score -3.13

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -6.3%

Returns

Return on Assets -38.3%

Return on Equity -52.8%

Return on Invested Capital -43.7%

Return on Capital Employed -43.7%

Return on Tangible Assets -43.4%

Historical Growth (CAGR)

Revenue CAGR 3Y -2.6%

Revenue CAGR 5Y 42.5%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 44.1%

EPS CAGR 5Y 26.8%

EPS CAGR 10Y N/A

FCF CAGR 3Y 6.8%

FCF CAGR 5Y -11.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 9

EPS Growth Next 3Y 21.1%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.12

EPS Growth Est (next Q) -62.5%

Revenue Est (next Q) $1.63M

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $7.50

Price Target Upside 305.4%

Cash Flow

Operating Cash Flow $-86.74M

Free Cash Flow $-88.53M

Adj. Free Cash Flow $-94.11M

FCF Per Share -$0.43

OCF Per Share -$0.42

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-25.53M

Operating Income $-118.8M

EBITDA $-95.09M

Net Income $-109.79M

EPS (Diluted) -$1.04

Revenue / Employee N/A

Profit / Employee $-1.41M

Employees 78